Assyro AI
FDA 483 Database

FDA Form 483s Issued in April 2024

Every published Form FDA 483 issued in April 2024, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

9

Published 483s in April 2024

9

Distinct firms

Form 483s issued in April 2024

CSL Behring GmbHFDA
FEI
3003098680
Issued
Apr 18, 2024
Establishment
Biologics & Medical Device Manufacturer
Location
Germany
Taenaka Kogyo Co., Ltd.FDA
FEI
3003282619
Issued
Apr 12, 2024
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Japan
Imprimis NJOF, LLCFDA
FEI
3013024146
Issued
Apr 3, 2024
Establishment
Outsourcing Facility
Location
New Jersey, United States
Denver Solutions LLC dba Leiters HealthFDA
FEI
3013438582
Issued
Apr 5, 2024
Establishment
Outsourcing Facility
Location
Colorado, United States
Chugai Pharma Manufacturing Co., Ltd.FDA
FEI
3006942691
Issued
Apr 2, 2024
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Delta Pharma, Inc.FDA
FEI
3004034796
Issued
Apr 12, 2024
Establishment
Outsourcing Facility
Location
Mississippi, United States
Zydus Lifesciences Ltd.FDA
FEI
3013712903
Issued
Apr 23, 2024
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Eugia Steriles Private LimitedFDA
FEI
3027357163
Issued
Apr 5, 2024
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Cipla LimitedFDA
FEI
3002806710
Issued
Apr 4, 2024
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
India

Other months in 2024

Back to the FDA 483 Database